4.7 Article Proceedings Paper

Thioredoxin1 as a negative regulator of cardiac hypertrophy

Journal

ANTIOXIDANTS & REDOX SIGNALING
Volume 9, Issue 6, Pages 679-687

Publisher

MARY ANN LIEBERT, INC
DOI: 10.1089/ars.2007.1529

Keywords

-

Funding

  1. NHLBI NIH HHS [HL 73048, HL67724, HL67727, HL 59139, HL69020] Funding Source: Medline

Ask authors/readers for more resources

Excessive reactive oxygen species (ROS) play an important role in the development of cardiac hypertrophy. In contrast, antioxidants scavenge ROS, thereby maintaining the reduced environment of cells and inhibiting hypertrophy in the heart. Thioredoxin1 (Trx1) not only functions as a major antioxidant in the heart but also interacts with important signaling molecules and transcription factors, thereby attenuating cardiac hypertrophy. This review will discuss the molecular mechanisms by which Trx1 exerts antihypertrophic effects in the heart.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available